Should I Buy PBI? PBI 2026 Analysis

Should You Buy Pitney Bowes Inc (PBI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

10.780

1 Day change

1.89%

52 Week Range

13.110

Analysis Updated At

2026/01/30

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now. PBI is trading pre-market around 10.2 (slightly down) and the technical setup is still bearish (SMA_200 > SMA_20 > SMA_5, MACD below zero). With no Intellectia buy signals today and weak recent quarter growth (2025/Q3 revenue and earnings down sharply YoY) plus heavy hedge-fund selling, the risk/reward is not attractive for an impatient buyer. If you want exposure, a better entry would typically come after a clear reclaim of the 10.36 pivot and improvement in momentum, but as of now the data supports waiting rather than buying immediately.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend/Momentum: Bearish. Moving averages are stacked negatively (SMA_200 > SMA_20 > SMA_5), indicating the broader downtrend remains intact. MACD histogram at -0.0415 is below zero (bearish), though it is negatively contracting, which can imply selling pressure is easing but not yet reversed. RSI_6 at ~46.97 is neutral—no oversold bounce signal.

Levels: Price (~10.2 pre-market) is below the pivot (10.359), which keeps the near-term bias cautious. Immediate support is S1 at 10.037 (break risks a push toward S2 at 9.837). Resistance levels to reclaim are 10.682 (R1) and 10.882 (R2). Given the bearish MA stack, rallies into resistance are more likely to face selling until the pivot is reclaimed with momentum.

Pattern-based odds: The provided analog-pattern stats imply only modest upside expectancy (about +0.41% next day, +0.51% next week, +1.46% next month), which is not compelling given the trend backdrop.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment/Positioning: Options positioning is notably call-heavy (OI put/call 0.2; volume put/call 0.46), which is generally bullish/optimistic versus typical neutral levels. Implied volatility (30D ~~45.96) is slightly above historical volatility (~~44.23), suggesting options are priced with a bit of extra risk premium. IV percentile ~37 and IV rank ~13 indicate IV is not extreme, so this is not a strong “panic” or “euphoria” read.

Liquidity/Activity: Today’s option volume (~990) is below the 5D/10D averages (1694/1386), implying sentiment is skewed bullish but not accompanied by a surge in trading activity. Net: mildly supportive sentiment, but not strong enough to override bearish price structure and weak fundamentals.

Technical Summary

Sell

Buy

Positive Catalysts

Bullish options skew: Very low put/call ratios suggest traders are leaning optimistic (call-heavy positioning).
Potential technical stabilization: MACD is still bearish but contracting, which can precede a base if price holds near support (10.037).
Upcoming earnings catalyst: QDEC 2025 earnings on 2026-02-17 (after hours) could re-rate shares if results/guide surprise.
Analyst upside exists: Citizens JMP initiated Outperform with a $13 target, citing compelling valuation and shareholder-friendly capital allocation.

Neutral/Negative Catalysts

Bearish trend structure: SMA_200 > SMA_20 > SMA_5 and price below pivot (10.
keep near-term bias negative.
Weak growth/earnings trajectory: 2025/Q3 showed revenue down ~7.97% YoY and large YoY deterioration in profitability metrics (net income/EPS down sharply), which weighs on investor confidence.
Secular headwinds: Analysts explicitly cite ongoing declines in mailing volumes as a structural drag and risk to forward sales estimates.
Institutional pressure: Hedge funds are selling, with selling amount up 713.33% over the last quarter.
No supportive news flow: No recent-week news catalysts to change the narrative in the immediate term.

Financial Performance

Latest quarter: 2025/Q3.

Revenue: 459,675,000, down -7.97% YoY (top-line contraction).
Net Income: 51,963,000, down -137.53% YoY (material deterioration vs prior-year quarter).
EPS: 0.30, down -138.96% YoY.
Gross Margin: 53.14%, up +1.51% YoY (some margin resilience), but it did not translate into improved bottom-line results.

Overall: The quarter shows weakening growth and profitability trends despite slightly better gross margin—fundamentally not the setup that typically supports an impatient “buy now.”

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Mixed/neutral-to-moderately-positive.

2025-11-03 Goldman Sachs: Neutral, PT $11 (valuation seen as balanced against secular declines).
2025-12-03 Citizens JMP: Outperform, PT $13 (sees compelling valuation and better capital allocation under new management).
2025-12-12 Truist: Hold, PT $11 (earnings base roughly flat into FY26; risks from declining mail volumes).

Wall Street pros: Market leadership in core niches; potential for shareholder-friendly capital allocation; at least one notable bullish initiation with higher PT. Wall Street cons: Structural decline in mailing volumes; expectation of flat earnings base; valuation viewed as fair by multiple firms.

Influential/political trading: No recent congress trading data available; insiders are neutral with no significant recent trend.

3 Analyst Rating

Wall Street analysts forecast PBI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PBI is 11.14 USD with a low forecast of 9.43 USD and a high forecast of 13 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

2 Hold

0 Sell

Moderate Buy

Current: 10.580

Low

9.43

Averages

11.14

High

Current: 10.580

Low

9.43

Averages

11.14

High

Truist

Jasper Bibb

Hold

initiated

$11

AI Analysis

2025-12-12

Reason

Truist

Jasper Bibb

Price Target

$11

AI Analysis

2025-12-12

initiated

Hold

Reason

Truist analyst Jasper Bibb initiated coverage of Pitney Bowes with a Hold rating and $11 price target. The company's earnings base is "roughly flat" into fiscal 2026 and the stock's valuation fairly reflects its profile as a cash-generative business in a challenged end market, the analyst tells investors in a research note. The firm says Pitney Bowes faces headwinds from ongoing declines in mailing volumes, which creates risk to 2027 sales estimates.

Citizens JMP

Outperform

initiated

$13

2025-12-03

Reason

Citizens JMP

Price Target

$13

2025-12-03

initiated

Outperform

Reason

Citizens JMP initiated coverage of Pitney Bowes with an Outperform rating and $13 price target. The firm says Pitney is the dominant player for sending and first-mile sortation of physical mail in the U.S. The company Pitney enjoys a market leadership position in both of its business segments and the shares at current levels offer a "compelling" valuation, the analyst tells investors in a research note. Citizens believes Pitney's new management has been decisive with shareholder-friendly capital allocation actions.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for PBI

Unlock Now

PBI Should I Buy

PBI Should I Buy

Should You Buy Pitney Bowes Inc (PBI) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch